Abrdn Life Sciences Investors (HQL) Competitors $12.86 -0.13 (-0.96%) Closing price 03:57 PM EasternExtended Trading$12.85 -0.01 (-0.04%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HQL vs. CET, GSBD, MFIC, NMFC, PFLT, BCSF, MUC, BBDC, AWF, and HQHShould you be buying Abrdn Life Sciences Investors stock or one of its competitors? The main competitors of Abrdn Life Sciences Investors include Central Securities (CET), Goldman Sachs BDC (GSBD), MidCap Financial Investment (MFIC), New Mountain Finance (NMFC), PennantPark Floating Rate Capital (PFLT), Bain Capital Specialty Finance (BCSF), BlackRock MuniHoldings California Quality Fund (MUC), Barings BDC (BBDC), AllianceBernstein Global High Income Fund (AWF), and Abrdn Healthcare Investors (HQH). These companies are all part of the "financial services" industry. Abrdn Life Sciences Investors vs. Its Competitors Central Securities Goldman Sachs BDC MidCap Financial Investment New Mountain Finance PennantPark Floating Rate Capital Bain Capital Specialty Finance BlackRock MuniHoldings California Quality Fund Barings BDC AllianceBernstein Global High Income Fund Abrdn Healthcare Investors Central Securities (NYSE:CET) and Abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, community ranking, analyst recommendations, earnings, institutional ownership, risk, dividends and media sentiment. Is CET or HQL more profitable? Company Net Margins Return on Equity Return on Assets Central SecuritiesN/A N/A N/A Abrdn Life Sciences Investors N/A N/A N/A Which has stronger valuation and earnings, CET or HQL? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCentral Securities$296.20M4.58N/AN/AN/AAbrdn Life Sciences Investors$86.69M4.28N/AN/AN/A Which has more volatility & risk, CET or HQL? Central Securities has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Comparatively, Abrdn Life Sciences Investors has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500. Do institutionals & insiders believe in CET or HQL? 8.7% of Central Securities shares are owned by institutional investors. Comparatively, 32.2% of Abrdn Life Sciences Investors shares are owned by institutional investors. 9.5% of Central Securities shares are owned by company insiders. Comparatively, 10.1% of Abrdn Life Sciences Investors shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is CET or HQL a better dividend stock? Central Securities pays an annual dividend of $2.30 per share and has a dividend yield of 4.9%. Abrdn Life Sciences Investors pays an annual dividend of $1.47 per share and has a dividend yield of 11.4%. Does the media refer more to CET or HQL? In the previous week, Central Securities' average media sentiment score of 0.59 beat Abrdn Life Sciences Investors' score of 0.00 indicating that Central Securities is being referred to more favorably in the media. Company Overall Sentiment Central Securities Positive Abrdn Life Sciences Investors Neutral Does the MarketBeat Community favor CET or HQL? Abrdn Life Sciences Investors received 95 more outperform votes than Central Securities when rated by MarketBeat users. CompanyUnderperformOutperformCentral SecuritiesN/AN/AAbrdn Life Sciences InvestorsOutperform Votes9568.35% Underperform Votes4431.65% SummaryCentral Securities and Abrdn Life Sciences Investors tied by winning 4 of the 8 factors compared between the two stocks. Get Abrdn Life Sciences Investors News Delivered to You Automatically Sign up to receive the latest news and ratings for HQL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HQL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HQL vs. The Competition Export to ExcelMetricAbrdn Life Sciences InvestorsInvestment offices IndustryFinance SectorNYSE ExchangeMarket Cap$371.15M$7.07B$11.61B$19.65BDividend Yield14.77%6.77%5.65%3.82%P/E RatioN/A3.5822.8035.03Price / Sales4.2824.4926.7642.85Price / CashN/A7.5117.6017.51Price / BookN/A0.912.844.78Net IncomeN/A$66.51M$1.04B$1.02B7 Day Performance0.67%0.00%-0.32%-0.35%1 Month Performance6.06%0.87%0.15%1.04%1 Year Performance-7.32%2.02%539.72%9.19% Abrdn Life Sciences Investors Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HQLAbrdn Life Sciences InvestorsN/A$12.86-1.0%N/A-6.2%$371.15M$86.69M0.00N/ACETCentral SecuritiesN/A$47.56+0.4%N/A+8.5%$1.38B$296.20M0.006Positive NewsGSBDGoldman Sachs BDC1.345 of 5 stars$11.60+0.8%$12.00+3.4%-24.3%$1.36B$67.93M16.57N/APositive NewsMFICMidCap Financial Investment2.183 of 5 stars$13.09+0.1%$14.00+7.0%-19.0%$1.22B$113.46M8.39N/ANews CoverageEx-DividendShort Interest ↑NMFCNew Mountain Finance2.4122 of 5 stars$10.83+0.6%$10.67-1.5%-14.0%$1.17B$118.17M10.31N/APositive NewsPFLTPennantPark Floating Rate Capital3.5628 of 5 stars$10.45+0.9%$11.08+6.1%-7.9%$1.04B$84.09M7.46658BCSFBain Capital Specialty Finance1.5815 of 5 stars$15.80+1.0%$16.50+4.4%-5.2%$1.02B$131.73M7.941,000MUCBlackRock MuniHoldings California Quality FundN/A$10.28-0.2%N/A-5.4%$987.32M$6.39M0.00147,000BBDCBarings BDC2.4888 of 5 stars$9.10+2.3%$9.67+6.3%-7.0%$958.70M$111.33M8.7526Positive NewsShort Interest ↑AWFAllianceBernstein Global High Income FundN/A$10.790.0%N/A+1.8%$929.99M$70.19M0.00N/AHQHAbrdn Healthcare InvestorsN/A$15.72+0.2%N/A-7.1%$846.71M$186.46M0.00147,000 Related Companies and Tools Related Companies CET Competitors GSBD Competitors MFIC Competitors NMFC Competitors PFLT Competitors BCSF Competitors MUC Competitors BBDC Competitors AWF Competitors HQH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HQL) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share Abrdn Life Sciences Investors With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HQL Stock Free HQL Stock Alerts